Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cryostar relies on IFS to drive its digital transformation in France and abroad

IFS Applications 10 will be deployed across Cryostar’s locations in France the United Kingdom, the United States, China, and Singapore London, September 2, 2019 - IFS , the global enterprise applications company, announces that is has been chosen by the French company Cryostar  to optimize the efficiency of its business processes.As an expert in advanced technologies for applications in Medical and Industrial Gas, Clean Energy, LNG (Liquified Natural Gas) and Hydrocarbons, for more than five decades, Cryostar has specialized in designing and

Clinical data for Episealer® accepted for presentation at German scientific congress

Episurf Medical (Nasdaq: EPIS B) today announces that the scientific abstract “Patient specific mini-metal implants. The future of cartilage repair for the right patient?” by Dr. med. J. Holz et al. has been accepted for presentation at the DKG (German Knee Society) annual congress in Hamburg, Germany, which will take place on November 22-23, 2019. The abstract focuses on clinical outcomes for patients in the “gap age”, 35-60 years old, that have undergone treatment of focal chondral defects using the knee implant Episealer®. The abstract shows excellent early clinical results from the

Process oil designed to perform in silicone sealant formulations

Nynas has launched NYFLEX® 2120B, a hydrotreated, very low viscosity naphthenic oil, which is a reliable and cost-efficient alternative to traditional silicone fluids.The FEICA European Adhesive and Sealant Conference & EXPO is a key event in the adhesive and sealant industry. Attracting influencers and decision makers from around the globe, delegates discuss the latest market drivers and trends, network with colleagues and customers, and look to the future with a focus on important topics such as developments in sustainability and technological advancements. Nynas, a sponsor of this

Enviro starts holding company in the USA as part of establishing local plants

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. The Board of Scandinavian Enviro Systems (publ) has decided to immediately start a holding company in the USA to facilitate Enviro's establishment of co-owned recycling plants on the US market. “Our new strategy means that Enviro wants to become part-owner of plants based on our technology as it provides good revenue opportunities. However, becoming a partner places other requirements on company

Ranplan is shifting to half-year reporting cycles

In pursuit of maximum operational efficiency, the Board of Directors of Ranplan Group AB has resolved that it is in the best interest of the Company to report its financial results on a half-year basis (aligned with requirements on First North).This means that the next interim report will coincide with the release of the full-year results in February 2020 (exact date to be determined later). In lieu of a separate Q3 2019 report, previously scheduled for 20 November, the Company plans to publish a brief summary of its financial performance along with an operational update for the period July-

Dignitana receives SEK 42 million in a directed new issue of units

Dignitana AB (publ) (“Dignitana” or the “Company”) today announced that the Company has successfully conducted a directed new issue of units consisting of shares and warrants, which has now raised proceeds to Dignitana of SEK 42 million before deduction of issue costs. These proceeds will be used to aggressively increase the growth rate of the company with a focus on the new scalp cooling device, DigniCap Delta. This new FDA cleared and CE marked system introduces an improved global business model consisting of one-time and recurring revenue. At full exercise of the warrants, Dignitana will

Bioservo Technologies signs additional distribution agreement in Europe

Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) has entered an exclusive distribution agreement with Health2Work for selling the all-new Ironhand® for the Dutch market.Health2Work is one of the largest players in the field of ergonomics in the Netherlands with the aim of advising on and taking care of healthy and efficient working environments. Their portfolio includes products such as seating solutions and assistive products for lifting, pushing and pulling. Amongst the company’s customers are Sodexo, KLM Royal Dutch Airlines, DAF Trucks NV and VDL Nedcar. Petter Bäckgren,

SCA invests in Obbola kraftliner mill

SCA to build a new paper machine for the production of kraftliner at its Obbola paper mill in Umeå. The annual production in Obbola will increase from the current 450,000 tonnes of kraftliner to 725,000 tonnes to meet the growing demand for renewable packaging. The investment amount is SEK 7.5 billion.SCA produces kraftliner – paper for transport packaging – at the paper mills in Obbola (Umeå) and Munksund (Piteå). SCA has today decided to invest to increase kraftliner capacity to 725,000 tonnes of kraftliner per year, an increase of 275,000 tonnes. The new paper machine will start

Brilinta reduced the risk of cardiovascular events in patients withcoronary artery disease and type-2 diabetes in Phase III THEMIS trial

02 September 2019 07:00 BST Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial Additionally, Brilinta showed a more favourable clinical benefit in a prespecified sub-analysis of patients who had undergone a procedure to open a coronary artery AstraZeneca today announced detailed results from the positive Phase III THEMIS trial which showed Brilinta (ticagrelor) plus aspirin reduced the relative risk for the composite of cardiovascular (CV) death, heart attack, or stroke by 10% compared with

Johan Hjertonsson assumes the position as CEO of Latour

In accordance with a previously published decision, Johan Hjertonsson assumed the position of President and CEO of Investment AB Latour (publ) on September 1, 2019. The decision was previously published through immediate publication on October 26, 2017. Göteborg, September 2, 2019 INVESTMENT AB LATOUR (PUBL)Olle NordströmChairman For further information, please contact:Olle Nordström, Chairman, +46 709 40 70 83 Investment AB Latour is a mixed investment company consisting primarily of a wholly-owned industrial operations and an investment portfolio of listing holdings in

Castellum and Einar Mattsson join forces in Hagastaden

Castellum and Einar Mattsson have signed an agreement to jointly develop the Sorbonne, Greifswald and Harvard blocks, all of which form part of Area D in Stockholm’s Hagastaden. The areas comprise approx. 23,000 square metres of office and commercial premises, and 150-170 residences.“We build and manage buildings – but our primary focus is not limited to walls, floors and ceilings. Our objective for the Hagastaden blocks is to create a space where synergies can be created between workplaces and residences, and where people and companies can grow and thrive together. The joint-project

Detailed results from Phase III DAPA-HF trial showed Farxigasignificantly reduced both the incidence of cardiovascular deathand the worsening of heart failure

02 September 2019 07:00 BST Detailed results from Phase III DAPA-HF trial showed Farxiga significantly reduced both the incidence of cardiovascular death and the worsening of heart failure DAPA-HF is the first outcomes trial with an SGLT2 inhibitor in patients with heart failure with reduced ejection fraction, with and without type-2 diabetes AstraZeneca today announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga (dapagliflozin) on top of standard of care reduced both the incidence of cardiovascular death and the worsening of heart failure.

Certification of the eQart® concept has been completed with positive results

The independent certification body SGS has evaluated the eQart® concept regarding the standards necessary for the European and North American market.The certification refers to compliance with both product, machine, and safety directives as follows: Machinery Directive 2006/42/EC Annex I, EN ISO 12100:2010, EN 1525, EN ISO 13849-1:2015, EN 60204-1:2006+A1:2009, EN 1175-1-1998+A1-2010, ANSI C63.4, 47 CFR PART 15B The certification refers to the modular concept eQart®, and not a specific size. The concept consists of engine modules, batteries, a control unit, and sensors which are

MTG Enters into Term Sheet with HUYA Inc. Regarding the Forming of a Joint Venture for China Esports Expansion and HUYA Investment into ESL

September 2nd, 2019 08.00am CEST — Modern Times Group MTG AB (MTG) today announces the entering into a binding term sheet and the forming of a strategic joint venture as part of a transaction that allows HUYA Inc. to acquire a minority stake in MTG’s portfolio company ESL.· Modern Times Group MTG AB (MTG) today announces the signing of a term sheet for a new strategic partnership with leading Chinese game live streaming platform HUYA Inc. (Huya).  · Pursuant to the term sheet, Huya has agreed to form a joint venture with MTG's portfolio company Turtle Entertainment GmbH (ESL), the

Herantis Pharma publishes newsletter for July-August

Herantis Pharma publishes newsletter for July-August Herantis Pharma PlcPress release 2 September 2019 at 9:00 am Herantis Pharma plc (“Herantis”) has published its newsletter for July-August 2019. The newsletter is also attached to this press release. Herantis’ newsletter is published every other month on the company’s web site . It is also available by email subscription . Further information: Herantis Pharma plc, Pekka Simula, CEO, telephone: +358 40 7300 445Company web site: www.herantis.com About

Insplorion sells an Acoulyte instrument to Professor Sibani Lisa Biswal at Rice University, Houston, USA

Professor Biswal’s research at Department of Chemical and Biomolecular Engineering at Rice University, focuses on using chemical, biological, and engineering approaches to study soft materials such as colloids, polymers, lipids, and surfactants. Professor Biswal and her team will use the Acoulyte mainly within their research on lipids, proteins and nanoparticle interactions.The Biswal group has extensive experience in using the acoustic QCM-D technology, which the Acoulyte combines to, within, among others, research covering lipid-surface interactions. A demo was set up earlier this year

Video interview with CEO Martin Vidaeus, August 27, 2019

CEO Martin Vidaeus presented the status of Redwood Pharma's Phase II trial for its RP101 program - a new treatment for post-menopausal women suffering from chronic, moderate to severe Dry Eye Disease.  About RP101RP101 is the company’s lead program for the development of a novel treatment of chronic dry eye disease in postmenopausal women. The active substance is an endogenous small molecule already proven safe and effective in two Phase II clinical trials in the US. The active substance for the first time has been formulated in IntelliGel to control its release, reduce dosing and

Investor AB supports intention to list EQT AB

Today EQT has announced its intention to strengthen its balance sheet by listing EQT AB on Nasdaq Stockholm. Investor supports this decision.  Investor was one of the founders of EQT in 1994 and has since its inception been an important sponsor of EQT’s funds. EQT has grown considerably during these 25 years and is today a leading manager of private equity and infrastructure funds with a total of 19 active funds and EUR 40 billion in assets under management.  “We support the intention to list EQT AB. A listing will provide further opportunities for EQT to grow and develop its

Nordnet digitalizes their insurance advisory process with help from Sharpfin

Nordnet has launched an innovative new system for insurance distribution to enhance the efficiency in their advisory process and to facilitate compliance with the Insurance Distribution Directive (IDD). Sharpfin AB – a Stockholm-based fintech company that develops state-of-the-art advisory support and portfolio management systems for asset managers, insurance distributors and banks – delivers the new system. “With Sharpfin, we take a major step forward in the digitalization of our advisory process. Sharpfin enables digital search and quality assurance of the advisory

Share buy-backs in Telia Company during week 35 2019

During the period August 26, 2019, until August 30, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,705,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back program that Telia Company announced on April 16, 2019. The share buy-back program, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period August

Polygiene Stays Fresh Technology Introduced in TOMMY HILFIGER Collection

Polygiene announces its partnership with one of the world's leading designer lifestyle brands Tommy Hilfiger, which is owned by PVH Corp. Polygiene® Stays Fresh Technology will be introduced in Spring 2020 TOMMY SPORT men’s and women’s tops, shorts and tank tops. “We are proud to partner with Tommy Hilfiger, one of the world's leading designer lifestyle brands,” says Ulrika Björk, CEO, Polygiene. “Polygiene addresses the need for sustainably minded fashion.” Polygiene® Stays Fresh Technology features an odor-control fabric treatment that inhibit the growth of odor-causing

Seadrill Limited Announces Contract Award for the West Neptune

Hamilton, Bermuda, September 2, 2019 - Seadrill Limited (“Seadrill”) has secured a one year contract with LLOG Exploration Offshore, L.L.C., (“LLOG”) for the West Neptune operating in the US Gulf of Mexico.  Total contract value is expected to be approximately $74 million with commencement in December 2019, in direct continuation of the existing contract with LLOG.  FORWARD LOOKING STATEMENTS This news release includes forward looking statements. Such statements are generally not historical in nature, and specifically include statements about the Company's plans, strategies, business

There are no items matching the current filter
There are no more items matching the current filter
Back to top